Dolby Laboratories

DLB Industrials Specialty Business Services

Dolby Laboratories' revenue for fiscal 2025 (year ended September 2025) was $1.3 billion, up 5.92% from fiscal 2024.

Revenue
−3.34%
EPS
−37.5%
Free cash flow
+157.4%

Quarter to June 2026, against a year earlier

64.77 1.45 +2.29%
Market cap
$5.9B
P/E
26.7×
Fwd P/E
20.0×
Dividend yield
2.26%
F-score
6/9
Altman Z
9.17
Beneish M
−2.80
Dividend safety
85/100

Dolby Laboratories (DLB) Shares outstanding

Alert me on Shares outstanding

Dolby Laboratories's shares outstanding at the end of fiscal 2025 was $97.5M, unchanged from fiscal 2024. At the end of the quarter to 30 June 2026 it was $94.5M. Over the past ten years it has ranged from $97.3M (fiscal 2024) to $107.0M (fiscal 2018); the current reading is higher than 18% of that period. Dolby Laboratories ranks 12th of 36 Specialty Business Services companies by shares outstanding.

Shares outstanding, annual

Embed this chart

Annual newest first

Period Shares outstanding Change
FY2025 $97.5M 0.16%
FY2024 $97.3M (0.42%)
FY2023 $97.7M (4.17%)
FY2022 $102.0M (2.52%)
FY2021 $104.6M 1.63%
FY2020 $102.9M (1.56%)
FY2019 $104.6M (2.25%)
FY2018 $107.0M 3.57%
FY2017 $103.3M 0.84%
FY2016 $102.4M (1.38%)

Quarterly newest first

Period Shares outstanding Change
Jun 2026 $94.5M (1.04%)
Mar 2026 $95.5M (1.04%)
Dec 2025 $96.5M (0.99%)
Sep 2025 $97.5M 0.60%
42 more quarters

Against its own ten years

Low $97.3M High $107.0M
Ten-year median $102.9M
Current reading's percentile 18

Shares outstanding against peers

What Shares outstanding is

Shares (Diluted, Weighted) tells an investor how many shares a company’s earnings are spread across once potential new shares are counted.

Reported line item

The full definition of Shares outstanding →

More on DLB